Abstract
This study sought to evaluate the ability of the proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor evolocumab to reduce the risk of complex coronary atherosclerosis requiring revascularization. PCSK9 inhibitors induce plaque regression and reduce the risk of coronary revascularization overall. FOURIER (Further Cardiovascular Outcomes Research with PCSK9 Inhibition in Subjects with Elevated Risk) was a randomized trial of the PCSK9 inhibitor evolocumab versus placebo in 27,564 patients with stable atherosclerotic cardiovascular disease on statin therapy followed for a median of 2.2 years. Clinical documentation of revascularization events was blindly reviewed to assess coronary anatomy and procedural characteristics. Complex revascularization was the composite of complex percutaneous coronary intervention (PCI) (as per previous analyses, ≥1 of: multivessel PCI, ≥3 stents, ≥3 lesions treated, bifurcation PCI, or total stent length >60 mm) or coronary artery bypass grafting surgery (CABG). In this study, 1,724 patients underwent coronary revascularization, including 1,482 who underwent PCI, 296 who underwent CABG, and 54 who underwent both. Complex revascularization was performed in 632 (37%) patients. Evolocumab red...Continue Reading
References
Dec 1, 1995·Journal of Clinical Epidemiology·J ConcatoA R Feinstein
Dec 1, 1995·Journal of Clinical Epidemiology·P PeduzziT R Holford
Sep 18, 2007·Journal of the American College of Cardiology·James K MinTracy Q Callister
Sep 4, 2008·The New England Journal of Medicine·Anne B RossebøUNKNOWN SEAS Investigators
Jun 4, 2015·The New England Journal of Medicine·Christopher P CannonUNKNOWN IMPROVE-IT Investigators
Nov 12, 2015·JAMA : the Journal of the American Medical Association·Sung-Jin HongUNKNOWN IVUS-XPL Investigators
Feb 28, 2016·American Heart Journal·Marc S SabatineTerje R Pedersen
Oct 22, 2016·Journal of the American College of Cardiology·Gennaro GiustinoAntonio Colombo
Nov 16, 2016·JAMA : the Journal of the American Medical Association·Stephen J NichollsSteven E Nissen
Mar 18, 2017·The New England Journal of Medicine·Marc S SabatineUNKNOWN FOURIER Steering Committee and Investigators
Jul 7, 2018·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Nikos WernerJan-Malte Sinning
Nov 14, 2018·Journal of the American College of Cardiology·Scott M GrundyJoseph Yeboah
Aug 10, 2019·European Heart Journal·Patrick W SerruysMarco Valgimigli
Apr 3, 2020·Journal of the American College of Cardiology·George DangasRoxana Mehran
Citations
Jan 23, 2021·Journal of the American College of Cardiology·E Magnus Ohman, Michael G Nanna
May 5, 2021·Cardiovascular Diabetology·Alberto J LorenzattiRobert S Rosenson
Sep 28, 2021·European Heart Journal Cardiovascular Imaging·Pierluigi DemolaRon Waksman
Oct 26, 2021·European Heart Journal·Carl E Orringer
Oct 19, 2021·Frontiers in Cardiovascular Medicine·Ping JinShaobin Jia